|Videos|March 11, 2020
Kiran Maski, MD, MPH: Addressing Pediatric Sleep Disorders
Author(s)Kiran Maski, MD, MPH
The director of the Sleep Clinic at Boston Children’s Hospital discussed the sleep disorders she sees in her practice, and how she and her colleagues best address these pediatric patients.
Advertisement
“We definitely rely on a team-based approach with academic liaisons to help with the return back to school, and with 504 plans or individualized education plans to help facilitate the management of problematic daytime sleepiness in a school setting.”
Sleep disorders can be a challenge for both patients and physicians. Conducting sleep studies is difficult and time-consuming, and many of the therapeutic approaches for these patients require a multidisciplinary model to fully address the condition at hand.
For Kiran Maski, MD, MPH, director, Sleep Clinic, Boston Children’s Hospital, and assistant professor of neurology, Harvard Medical School, these challenges are coupled with the challenges in treating children. Maski and colleagues have treated a number of sleep disorders in pediatric patients, including insomnia, circadian rhythm disorders, obstructive sleep apnea (OSA), and even narcolepsy.
In a discussion with NeurologyLive, she offered an overview of the patients that she sees at Boston Children’s, as well as the comorbid conditions which can accompany these disorders. Maski offered insight into how she and colleagues address the management of these patients and how a team-based approach, including even a cognitive behavior therapist, is utilized.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
3
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
4
NeurologyLive® Friday 5 — September 12, 2025
5